S, R., K, G., P, A., S, P., RK, N., V, V., . . . MP, P. (2023). Elevated PAF1-RAD52 axis confers chemoresistance to human cancers. Cell reports, 42(2), 112043. https://doi.org/10.1016/j.celrep.2023.112043
Chicago Style (17th ed.) CitationS, Rauth, et al. "Elevated PAF1-RAD52 Axis Confers Chemoresistance to Human Cancers." Cell Reports 42, no. 2 (2023): 112043. https://doi.org/10.1016/j.celrep.2023.112043.
MLA (9th ed.) CitationS, Rauth, et al. "Elevated PAF1-RAD52 Axis Confers Chemoresistance to Human Cancers." Cell Reports, vol. 42, no. 2, 2023, p. 112043, https://doi.org/10.1016/j.celrep.2023.112043.
Warning: These citations may not always be 100% accurate.